KOPRAN Financial Statement Analysis
|
||
|
The Revenues of KOPRAN have increased by 11.54% YoY .
The Earnings Per Share (EPS) of KOPRAN has decreased by -24.50 % YoY. |
||
KOPRAN Last 5 Annual Financial Results
[BOM: 524280|NSE : KOPRAN]
| Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Revenues | ₹615 Cr | ₹551 Cr | ₹478 Cr | ₹492 Cr | ₹359 Cr |
| Expenses | ₹540 Cr | ₹499 Cr | ₹390 Cr | ₹410 Cr | ₹313 Cr |
| Operating Profit (Excl OI) | ₹74 Cr | ₹52 Cr | ₹87 Cr | ₹82 Cr | ₹47 Cr |
| Other Income | ₹15 Cr | ₹3.07 Cr | ₹11 Cr | ₹18 Cr | ₹0.63 Cr |
| Interest | ₹8.59 Cr | ₹6.08 Cr | ₹5.12 Cr | ₹6.24 Cr | ₹8.91 Cr |
| Depreciation | ₹13 Cr | ₹13 Cr | ₹11 Cr | ₹10 Cr | ₹9.58 Cr |
| Profit Before Tax | ₹68 Cr | ₹36 Cr | ₹82 Cr | ₹83 Cr | ₹28 Cr |
| Profit After Tax | ₹51 Cr | ₹27 Cr | ₹61 Cr | ₹62 Cr | ₹21 Cr |
| Consolidated Net Profit | ₹51 Cr | ₹27 Cr | ₹61 Cr | ₹62 Cr | ₹21 Cr |
| Earnings Per Share (Rs) | ₹7.98 | ₹10.57 | ₹5.65 | ₹12.66 | ₹14.24 |
| PAT Margin (%) | 6.12 | 8.29 | 4.88 | 12.60 | 12.29 |
| ROE(%) | 7.66 | 10.96 | 6.29 | 18.19 | 28.34 |
| ROCE(%) | 9.75 | 13.78 | 8.30 | 21.40 | 30.40 |
| Total Debt/Equity(x) | 0.29 | 0.20 | 0.17 | 0.17 | 0.27 |
Key Financials |
||
| Market Cap | : | ₹ 627.7 Cr |
| Revenue (TTM) | : | ₹ 619.8 Cr |
| Net Profit(TTM) | : | ₹ 16.5 Cr |
| EPS (TTM) | : | ₹ 3.4 |
| P/E (TTM) | : | 37.9 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| KOPRAN | -2.9% | -4.3% | -17.8% |
| SUN PHARMACEUTICAL INDUSTRIES | 1.5% | 5.5% | 0.5% |
| DIVIS LABORATORIES | 2.3% | 3.6% | 7.8% |
| CIPLA | -1.1% | -2.2% | -8.9% |
| TORRENT PHARMACEUTICALS | -0.5% | 5.3% | 40.2% |
| DR REDDYS LABORATORIES | 0.9% | 5.2% | 7% |
| MANKIND PHARMA | -2.6% | -5.6% | -15% |
| ZYDUS LIFESCIENCES | -1% | 1.8% | 0.1% |
| LUPIN | -0% | 2.5% | 13.2% |
KOPRAN Revenues
[BOM: 524280|NSE : KOPRAN]
| Y-o-Y | 11.54 % |
| 5 Yr CAGR | 14.35 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹615 Cr | 11.54 | |
| Mar2024 | ₹551 Cr | 15.38 | |
| Mar2023 | ₹478 Cr | -2.91 | |
| Mar2022 | ₹492 Cr | 36.81 | |
| Mar2021 | ₹359 Cr | - | |
KOPRAN Operating Profit
[BOM: 524280|NSE : KOPRAN]
| Y-o-Y | 43.56 % |
| 5 Yr CAGR | 12.33 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹74 Cr | 43.56 | |
| Mar2024 | ₹52 Cr | -40.63 | |
| Mar2023 | ₹87 Cr | 6.89 | |
| Mar2022 | ₹82 Cr | 74.78 | |
| Mar2021 | ₹47 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 28.72 % |
| 5 Yr CAGR | -1.76 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 12.1% | 28.72 | |
| Mar2024 | 9.4% | -48.55 | |
| Mar2023 | 18.27% | 10.13 | |
| Mar2022 | 16.59% | 27.71 | |
| Mar2021 | 12.99% | - | |
KOPRAN Profit After Tax
[BOM: 524280|NSE : KOPRAN]
| Y-o-Y | 87.11 % |
| 5 Yr CAGR | 24.78 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹51 Cr | 87.11 | |
| Mar2024 | ₹27 Cr | -55.38 | |
| Mar2023 | ₹61 Cr | -0.93 | |
| Mar2022 | ₹62 Cr | 193.08 | |
| Mar2021 | ₹21 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -26.18 % |
| 5 Yr CAGR | -16.00 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 6.12 % | -26.18 | |
| Mar2024 | 8.29 % | 69.88 | |
| Mar2023 | 4.88 % | -61.27 | |
| Mar2022 | 12.6 % | 2.52 | |
| Mar2021 | 12.29 % | - | |
KOPRAN Earnings Per Share (EPS)
[BOM: 524280|NSE : KOPRAN]
| Y-o-Y | -24.50 % |
| 5 Yr CAGR | -13.48 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹7.98 | -24.50 | |
| Mar2024 | ₹11 | 87.08 | |
| Mar2023 | ₹5.65 | -55.37 | |
| Mar2022 | ₹13 | -11.10 | |
| Mar2021 | ₹14 | - | |
KOPRAN Return on Capital Employed (ROCE)
[BOM: 524280|NSE : KOPRAN]
| Y-o-Y | -29.25 % |
| 5 Yr CAGR | -24.75 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 9.75% | -29.25 | |
| Mar2024 | 13.78% | 66.02 | |
| Mar2023 | 8.3% | -61.21 | |
| Mar2022 | 21.4% | -29.61 | |
| Mar2021 | 30.4% | - | |
KOPRAN Share Price vs Sensex
| Current Share Price | : | ₹130.0 |
| Current MarketCap | : | ₹ 627.7 Cr |
| Updated EOD on | : | Feb 20,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | -2.9% |
-4.3% |
-17.8% |
| SENSEX | 0.2% |
1.1% |
8.8% |
KOPRAN related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
| BSE HEALTHCARE | 1.1% | 4.2% | 5% |
| BSE SMALLCAP | -5.8% | -8.9% | -10.5% |
No NSE index found
You may also like the below Video Courses
FAQ about KOPRAN Financials
How the annual revenues of KOPRAN have changed ?
The Revenues of KOPRAN have increased by 11.54% YoY .
How the Earnings per Share (EPS) of KOPRAN have changed?
The Earnings Per Share (EPS) of KOPRAN has decreased by -24.50 % YoY .
Check out Intrinsic Value of Peers of KOPRAN
Compare Stock Analytics of Peers of KOPRAN
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
